Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancerGiacomo Oliveira, Ravindra Uppaluri, Ann Marie Egloff et al.|Science Immunology|2023Cited by 118
Enhanced pathologic tumor response with two cycles of neoadjuvant pembrolizumab in surgically resectable, locally advanced HPV-negative head and neck squamous cell carcinoma (HNSCC).Ravindra Uppaluri, Douglas R. Adkins, Rebecca D. Chernock et al.|Journal of Clinical Oncology|2021Cited by 40
Characterization of Advanced <i>RAS</i> -driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic AvenuesSarah Hamidi, Maria E. Cabanillas, Renata Ferrarotto et al.|The Journal of Clinical Endocrinology & Metabolism|2025Cited by 5